The mutual crosstalk between iron and erythropoiesis

被引:14
作者
Camaschella, Clara [1 ]
Pagani, Alessia [1 ]
Silvestri, Laura [1 ,2 ]
Nai, Antonella [1 ,2 ]
机构
[1] IRCCS San Raffaele, Div Genet & Cell Biol, Via Olgettina 60, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
关键词
Iron; Hepcidin; Erythropoiesis; Transferrin receptor; Anemia; TRANSFERRIN RECEPTOR 2; HEPCIDIN EXPRESSION; PULMONARY-HYPERTENSION; BETA-THALASSEMIA; MURINE MODELS; ANEMIA; TMPRSS6; HEMOCHROMATOSIS; ERYTHROFERRONE; FERROPORTIN;
D O I
10.1007/s12185-022-03384-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Iron homeostasis and erythropoiesis are strongly interconnected. On one side iron is essential to terminal erythropoiesis for hemoglobin production, on the other erythropoiesis may increase iron absorption through the production of erythroferrone, the erythroid hormone that suppresses hepcidin expression Also erythropoietin production is modulated by iron through the iron regulatory proteins-iron responsive elements that control the hypoxia inducible factor 2-alpha. The second transferrin receptor, an iron sensor both in the liver and in erythroid cells modulates erythropoietin sensitivity and is a further link between hepcidin and erythropoiesis. When erythropoietin is decreased in iron deficiency the erythropoietin sensitivity is increased because the second transferrin receptor is removed from cell surface. A deranged balance between erythropoiesis and iron/hepcidin may lead to anemia, as in the case of iron deficiency, defective iron uptake and erythroid utilization or subnormal recycling. Defective control of hepcidin production may cause iron deficiency, as in the recessive disorder iron refractory iron deficiency anemia or in anemia of inflammation, or in iron loading anemias, which are characterized by excessive but ineffective erythropoiesis. The elucidation of the mechanisms that regulates iron homeostasis and erythropoiesis is leading to the development of drugs for the benefit of both iron and erythropoiesis disorders.
引用
收藏
页码:182 / 191
页数:10
相关论文
共 81 条
[11]   Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms [J].
Billesbolle, Christian B. ;
Azumaya, Caleigh M. ;
Kretsch, Rachael C. ;
Powers, Alexander S. ;
Gonen, Shane ;
Schneider, Simon ;
Arvedson, Tara ;
Dror, Ron O. ;
Cheng, Yifan ;
Manglik, Aashish .
NATURE, 2020, 586 (7831) :807-+
[12]   The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 [J].
Camaschella, C ;
Roetto, A ;
Cali, A ;
De Gobbi, M ;
Garozzo, G ;
Carella, M ;
Majorano, N ;
Totaro, A ;
Gasparini, P .
NATURE GENETICS, 2000, 25 (01) :14-15
[13]   The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload [J].
Camaschella, Clara ;
Campanella, Alessandro ;
De Falco, Luigia ;
Boschetto, Loredana ;
Merlini, Roberta ;
Silvestri, Laura ;
Levi, Sonia ;
Iolascon, Achille .
BLOOD, 2007, 110 (04) :1353-1358
[14]   Mendelian inheritance of anemia due to disturb e d iron homeostasis [J].
Camaschella, Clara ;
Pagani, Alessia .
SEMINARS IN HEMATOLOGY, 2021, 58 (03) :175-181
[15]   The changing landscape of iron deficiency [J].
Camaschella, Clara ;
Girelli, Domenico .
MOLECULAR ASPECTS OF MEDICINE, 2020, 75
[16]   Ineffective erythropoiesis and regulation of iron status in iron loading anaemias [J].
Camaschella, Clara ;
Nai, Antonella .
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (04) :512-523
[17]   Iron-Deficiency Anemia [J].
Camaschella, Clara .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19) :1832-1843
[18]   A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia [J].
Cappellini, M. D. ;
Viprakasit, V. ;
Taher, A. T. ;
Georgiev, P. ;
Kuo, K. H. M. ;
Coates, T. ;
Voskaridou, E. ;
Liew, H. -K. ;
Pazgal-Kobrowski, I. ;
Forni, G. L. ;
Perrotta, S. ;
Khelif, A. ;
Lal, A. ;
Kattamis, A. ;
Vlachaki, E. ;
Origa, R. ;
Aydinok, Y. ;
Bejaoui, M. ;
Ho, P. J. ;
Chew, L. -P. ;
Bee, P. -C. ;
Lim, S. -M. ;
Lu, M. -Y. ;
Tantiworawit, A. ;
Ganeva, P. ;
Gercheva, L. ;
Shah, F. ;
Neufeld, E. J. ;
Thompson, A. ;
Laadem, A. ;
Shetty, J. K. ;
Zou, J. ;
Zhang, J. ;
Miteva, D. ;
Zinger, T. ;
Linde, P. G. ;
Sherman, M. L. ;
Hermine, O. ;
Porter, J. ;
Piga, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (13) :1219-1231
[19]   The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry [J].
Castro-Mollo, Melanie ;
Gera, Sakshi ;
Ruiz-Martinez, Marc ;
Feola, Maria ;
Gumerova, Anisa ;
Planoutene, Marina ;
Clementelli, Cara ;
Sangkhae, Veena ;
Casu, Carla ;
Kim, Se-Min ;
Ostland, Vaughn ;
Han, Huiling ;
Nemeth, Elizabeta ;
Fleming, Robert ;
Rivella, Stefano ;
Lizneva, Daria ;
Yuen, Tony ;
Zaidi, Mone ;
Ginzburg, Yelena .
ELIFE, 2021, 10
[20]   Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity [J].
Casu, Carla ;
Pettinato, Mariateresa ;
Liu, Alison ;
Aghajan, Mariam ;
Lo Presti, Vania ;
Lidonnici, Maria Rosa ;
Munoz, Kevin A. ;
O'Hara, Emir ;
Olivari, Violante ;
Di Modica, Simona Maria ;
Booten, Sheri ;
Guo, Shuling ;
Neil, Garry ;
Miari, Reem ;
Shapir, Nir ;
Zafir-Lavie, Inbal ;
Domev, Hagit ;
Ferrari, Giuliana ;
Sitara, Despina ;
Nai, Antonella ;
Rivella, Stefano .
BLOOD, 2020, 136 (17) :1968-1979